drugset / Trial / NCT01473108
Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862
RandomizedCrossoverSingle-blindOther
Summary
Pharmacodynamics, pharmacokinetics, safety, and tolerability will be investigated in this single dose study. In 5 treatment groups, different dosages of BAY94-8862 will be given in healthy male subjects.
Timeline
- Start
- 2010-03-29
- Primary completion
- 2010-11-30
- Completion
- 2011-05-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eplerenone | Unknown | 50 mg | Oral |
| Subject | Finerenone | Small molecule | 2.5 mg | Oral |
| Subject | Finerenone | Small molecule | 5 mg | Oral |
| Subject | Finerenone | Small molecule | 10 mg | Oral |
| Subject | Finerenone | Small molecule | 20 mg | Oral |
Indications
No indication recorded.